
Market Analysis and Insights: Global Transcriptome Sequencing Market
The global Transcriptome Sequencing market is projected to grow from US$ 2206.2 million in 2024 to US$ 5532.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 16.6% during the forecast period.
The key service providers of Transcriptome Sequencing in the world are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences and Eurofins Scientific, among which the top five providers account for more than 70% of the market share, and Illumina is the largest service provider. The global transcriptome sequencing service providers are mainly distributed in North America, Europe, China and Japan, among which the market share of the top three regions is close to 80%. At present, North America is the largest service provider region. In terms of its service type, the growth rate of noncoding RNA is relatively fast. At present, the market share of coding RNA is high, close to 80%. In terms of its application, biomedicine is the largest application field, with a market share of more than 85%, followed by non-medical fields.
Report Covers:
This report presents an overview of global market for Transcriptome Sequencing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Transcriptome Sequencing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Transcriptome Sequencing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transcriptome Sequencing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Transcriptome Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Transcriptome Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang Biology
Novogene Co., Ltd
Macrogen
Tsingke Biotechnology Co., Ltd.
Segment by Type
Coding RNA
Noncoding RNA
Segment by Application
Biomedical Field
Non-medical Field
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Transcriptome Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcriptome Sequencing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcriptome Sequencing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcriptome Sequencing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Coding RNA
1.2.3 Noncoding RNA
1.3 Market by Application
1.3.1 Global Transcriptome Sequencing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Biomedical Field
1.3.3 Non-medical Field
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcriptome Sequencing Market Perspective (2019-2030)
2.2 Global Transcriptome Sequencing Growth Trends by Region
2.2.1 Transcriptome Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transcriptome Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Transcriptome Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Transcriptome Sequencing Market Dynamics
2.3.1 Transcriptome Sequencing Industry Trends
2.3.2 Transcriptome Sequencing Market Drivers
2.3.3 Transcriptome Sequencing Market Challenges
2.3.4 Transcriptome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Transcriptome Sequencing by Players
3.1.1 Global Transcriptome Sequencing Revenue by Players (2019-2024)
3.1.2 Global Transcriptome Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Transcriptome Sequencing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Transcriptome Sequencing Market Concentration Ratio
3.4.1 Global Transcriptome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcriptome Sequencing Revenue in 2023
3.5 Global Key Players of Transcriptome Sequencing Head office and Area Served
3.6 Global Key Players of Transcriptome Sequencing, Product and Application
3.7 Global Key Players of Transcriptome Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transcriptome Sequencing Breakdown Data by Type
4.1 Global Transcriptome Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Transcriptome Sequencing Forecasted Market Size by Type (2025-2030)
5 Transcriptome Sequencing Breakdown Data by Application
5.1 Global Transcriptome Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Transcriptome Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transcriptome Sequencing Market Size (2019-2030)
6.2 North America Transcriptome Sequencing Market Size by Type
6.2.1 North America Transcriptome Sequencing Market Size by Type (2019-2024)
6.2.2 North America Transcriptome Sequencing Market Size by Type (2025-2030)
6.2.3 North America Transcriptome Sequencing Market Share by Type (2019-2030)
6.3 North America Transcriptome Sequencing Market Size by Application
6.3.1 North America Transcriptome Sequencing Market Size by Application (2019-2024)
6.3.2 North America Transcriptome Sequencing Market Size by Application (2025-2030)
6.3.3 North America Transcriptome Sequencing Market Share by Application (2019-2030)
6.4 North America Transcriptome Sequencing Market Size by Country
6.4.1 North America Transcriptome Sequencing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Transcriptome Sequencing Market Size by Country (2019-2024)
6.4.3 North America Transcriptome Sequencing Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Transcriptome Sequencing Market Size (2019-2030)
7.2 Europe Transcriptome Sequencing Market Size by Type
7.2.1 Europe Transcriptome Sequencing Market Size by Type (2019-2024)
7.2.2 Europe Transcriptome Sequencing Market Size by Type (2025-2030)
7.2.3 Europe Transcriptome Sequencing Market Share by Type (2019-2030)
7.3 Europe Transcriptome Sequencing Market Size by Application
7.3.1 Europe Transcriptome Sequencing Market Size by Application (2019-2024)
7.3.2 Europe Transcriptome Sequencing Market Size by Application (2025-2030)
7.3.3 Europe Transcriptome Sequencing Market Share by Application (2019-2030)
7.4 Europe Transcriptome Sequencing Market Size by Country
7.4.1 Europe Transcriptome Sequencing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Transcriptome Sequencing Market Size by Country (2019-2024)
7.4.3 Europe Transcriptome Sequencing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Transcriptome Sequencing Market Size (2019-2030)
8.2 China Transcriptome Sequencing Market Size by Type
8.2.1 China Transcriptome Sequencing Market Size by Type (2019-2024)
8.2.2 China Transcriptome Sequencing Market Size by Type (2025-2030)
8.2.3 China Transcriptome Sequencing Market Share by Type (2019-2030)
8.3 China Transcriptome Sequencing Market Size by Application
8.3.1 China Transcriptome Sequencing Market Size by Application (2019-2024)
8.3.2 China Transcriptome Sequencing Market Size by Application (2025-2030)
8.3.3 China Transcriptome Sequencing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Transcriptome Sequencing Market Size (2019-2030)
9.2 Asia Transcriptome Sequencing Market Size by Type
9.2.1 Asia Transcriptome Sequencing Market Size by Type (2019-2024)
9.2.2 Asia Transcriptome Sequencing Market Size by Type (2025-2030)
9.2.3 Asia Transcriptome Sequencing Market Share by Type (2019-2030)
9.3 Asia Transcriptome Sequencing Market Size by Application
9.3.1 Asia Transcriptome Sequencing Market Size by Application (2019-2024)
9.3.2 Asia Transcriptome Sequencing Market Size by Application (2025-2030)
9.3.3 Asia Transcriptome Sequencing Market Share by Application (2019-2030)
9.4 Asia Transcriptome Sequencing Market Size by Region
9.4.1 Asia Transcriptome Sequencing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Transcriptome Sequencing Market Size by Region (2019-2024)
9.4.3 Asia Transcriptome Sequencing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Transcriptome Sequencing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Transcriptome Sequencing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Transcriptome Sequencing Introduction
11.1.4 Illumina Revenue in Transcriptome Sequencing Business (2019-2024)
11.1.5 Illumina Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Transcriptome Sequencing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Transcriptome Sequencing Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Transcriptome Sequencing Introduction
11.3.4 Bio-Rad Revenue in Transcriptome Sequencing Business (2019-2024)
11.3.5 Bio-Rad Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Transcriptome Sequencing Introduction
11.4.4 Agilent Technologies Revenue in Transcriptome Sequencing Business (2019-2024)
11.4.5 Agilent Technologies Recent Developments
11.5 QIAGEN
11.5.1 QIAGEN Company Details
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Transcriptome Sequencing Introduction
11.5.4 QIAGEN Revenue in Transcriptome Sequencing Business (2019-2024)
11.5.5 QIAGEN Recent Developments
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Transcriptome Sequencing Introduction
11.6.4 Roche Revenue in Transcriptome Sequencing Business (2019-2024)
11.6.5 Roche Recent Developments
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Company Details
11.7.2 Pacific Biosciences Business Overview
11.7.3 Pacific Biosciences Transcriptome Sequencing Introduction
11.7.4 Pacific Biosciences Revenue in Transcriptome Sequencing Business (2019-2024)
11.7.5 Pacific Biosciences Recent Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific Transcriptome Sequencing Introduction
11.8.4 Eurofins Scientific Revenue in Transcriptome Sequencing Business (2019-2024)
11.8.5 Eurofins Scientific Recent Developments
11.9 Azenta
11.9.1 Azenta Company Details
11.9.2 Azenta Business Overview
11.9.3 Azenta Transcriptome Sequencing Introduction
11.9.4 Azenta Revenue in Transcriptome Sequencing Business (2019-2024)
11.9.5 Azenta Recent Developments
11.10 LabCorp
11.10.1 LabCorp Company Details
11.10.2 LabCorp Business Overview
11.10.3 LabCorp Transcriptome Sequencing Introduction
11.10.4 LabCorp Revenue in Transcriptome Sequencing Business (2019-2024)
11.10.5 LabCorp Recent Developments
11.11 BGI Genomics
11.11.1 BGI Genomics Company Details
11.11.2 BGI Genomics Business Overview
11.11.3 BGI Genomics Transcriptome Sequencing Introduction
11.11.4 BGI Genomics Revenue in Transcriptome Sequencing Business (2019-2024)
11.11.5 BGI Genomics Recent Developments
11.12 Zhijiang Biology
11.12.1 Zhijiang Biology Company Details
11.12.2 Zhijiang Biology Business Overview
11.12.3 Zhijiang Biology Transcriptome Sequencing Introduction
11.12.4 Zhijiang Biology Revenue in Transcriptome Sequencing Business (2019-2024)
11.12.5 Zhijiang Biology Recent Developments
11.13 Novogene Co., Ltd
11.13.1 Novogene Co., Ltd Company Details
11.13.2 Novogene Co., Ltd Business Overview
11.13.3 Novogene Co., Ltd Transcriptome Sequencing Introduction
11.13.4 Novogene Co., Ltd Revenue in Transcriptome Sequencing Business (2019-2024)
11.13.5 Novogene Co., Ltd Recent Developments
11.14 Macrogen
11.14.1 Macrogen Company Details
11.14.2 Macrogen Business Overview
11.14.3 Macrogen Transcriptome Sequencing Introduction
11.14.4 Macrogen Revenue in Transcriptome Sequencing Business (2019-2024)
11.14.5 Macrogen Recent Developments
11.15 Tsingke Biotechnology Co., Ltd.
11.15.1 Tsingke Biotechnology Co., Ltd. Company Details
11.15.2 Tsingke Biotechnology Co., Ltd. Business Overview
11.15.3 Tsingke Biotechnology Co., Ltd. Transcriptome Sequencing Introduction
11.15.4 Tsingke Biotechnology Co., Ltd. Revenue in Transcriptome Sequencing Business (2019-2024)
11.15.5 Tsingke Biotechnology Co., Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang Biology
Novogene Co., Ltd
Macrogen
Tsingke Biotechnology Co., Ltd.
Ìý
Ìý
*If Applicable.
